J Midgley

743 total citations
21 papers, 403 citations indexed

About

J Midgley is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J Midgley has authored 21 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J Midgley's work include Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Antifungal resistance and susceptibility (8 papers) and HIV/AIDS oral health manifestations (7 papers). J Midgley is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Antifungal resistance and susceptibility (8 papers) and HIV/AIDS oral health manifestations (7 papers). J Midgley collaborates with scholars based in United Kingdom, India and Nepal. J Midgley's co-authors include Brian Gazzard, D.C. Shanson, David Johnstone, Don Smith, S. A. Howell, G M Connolly, S. P. Sweet, B G Gazzard, Richard Anthony and S. P. Lapage and has published in prestigious journals such as The Lancet, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

J Midgley

21 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Midgley United Kingdom 13 253 219 90 44 43 21 403
M V Borobio Spain 11 123 0.5× 114 0.5× 61 0.7× 55 1.3× 24 0.6× 24 407
Sander Koning Netherlands 8 164 0.6× 165 0.8× 73 0.8× 52 1.2× 125 2.9× 18 399
Julie Bonhomme France 11 335 1.3× 229 1.0× 18 0.2× 129 2.9× 16 0.4× 41 580
Andrea D’Ávila Freitas Brazil 10 275 1.1× 203 0.9× 216 2.4× 51 1.2× 9 0.2× 17 505
Mary M. Carruthers United States 11 119 0.5× 137 0.6× 51 0.6× 50 1.1× 11 0.3× 21 346
Steven A. Holloway Australia 12 126 0.5× 178 0.8× 204 2.3× 62 1.4× 27 0.6× 16 535
Ronaldo Rozenbaum Brazil 10 410 1.6× 307 1.4× 42 0.5× 135 3.1× 4 0.1× 14 490
B L Wetherall Australia 10 84 0.3× 104 0.5× 45 0.5× 32 0.7× 4 0.1× 15 324
AV Hill Australia 7 135 0.5× 275 1.3× 41 0.5× 122 2.8× 109 2.5× 24 542
Şehnaz Alp Türkiye 11 220 0.9× 153 0.7× 38 0.4× 30 0.7× 4 0.1× 29 320

Countries citing papers authored by J Midgley

Since Specialization
Citations

This map shows the geographic impact of J Midgley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Midgley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Midgley more than expected).

Fields of papers citing papers by J Midgley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Midgley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Midgley. The network helps show where J Midgley may publish in the future.

Co-authorship network of co-authors of J Midgley

This figure shows the co-authorship network connecting the top 25 collaborators of J Midgley. A scholar is included among the top collaborators of J Midgley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Midgley. J Midgley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Midgley, J, et al.. (1999). A RANDOMISED, DOUBLE‐BLIND STUDY OF ITRACONAZOLE VERSUS PLACEBO IN THE TREATMENT AND PREVENTION OF ORAL OR OESOPHAGEAL CANDIDOSIS IN PATIENTS WITH HIV INFECTION. International Journal of Clinical Practice. 53(5). 349–352. 15 indexed citations
2.
Denning, David W., B. Dupont, Nathan Clumeck, et al.. (1998). Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal. AIDS. 12(4). 411–416. 7 indexed citations
3.
Midgley, J, et al.. (1997). Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis. AIDS. 11(15). 1839–1844. 48 indexed citations
4.
Cartledge, J D, J Midgley, Michael A. Petrou, D.C. Shanson, & B G Gazzard. (1997). Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests. Journal of Antimicrobial Chemotherapy. 40(4). 517–523. 20 indexed citations
5.
Midgley, J, et al.. (1997). Itraconazole cyclodextrin solution. AIDS. 11(2). 163–168. 30 indexed citations
6.
Cartledge, J D, J Midgley, & B Gazzard. (1997). Prior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: a case-control study.. Sexually Transmitted Infections. 73(6). 471–474. 5 indexed citations
7.
Nandwani, Rak, M Youle, Charles Lacey, et al.. (1996). Use of terbinafine in HIV-positive subjects: pilot studies in onychomycosis and oral candidiasis. British Journal of Dermatology. 134. 22–24. 22 indexed citations
8.
Anthony, Richard, J Midgley, S. P. Sweet, & S. A. Howell. (1995). Multiple Strains of Candida albicans in the Oral Cavity of HIV Positive and HIV Negative Patients. Microbial Ecology in Health and Disease. 8(1). 23–30. 18 indexed citations
9.
Anthony, Richard, J Midgley, S. P. Sweet, & S. A. Howell. (1994). Multiple Strains ofCandidu albicansin the Oral Cavity of HIV Positive and HIV Negative Patients. Microbial Ecology in Health and Disease. 8(1). 21 indexed citations
10.
Cartledge, J D, J Midgley, M Youle, Martin Fisher, & Brian Gazzard. (1993). The use of cyclodextrin solution formulation of itraconazole to treat candidiasis unresponsive to other azole preparations in patients with AIDS. 55. 1 indexed citations
11.
Midgley, J, et al.. (1991). Monoclonal immunofluorescence compared with silver stain for investigating Pneumocystis carinii pneumonia.. Journal of Clinical Pathology. 44(1). 75–76. 12 indexed citations
12.
Smith, Don, et al.. (1991). Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. AIDS. 5(11). 1367–1372. 51 indexed citations
13.
Smith, Don, et al.. (1991). Disseminated histoplasmosis in an AIDS patient treated with itraconazole.. Sexually Transmitted Infections. 67(4). 342–344. 5 indexed citations
14.
Moyle, G, Samantha Barton, J Midgley, et al.. (1990). Gonococcal arthritis caused by auxotype P in a man with HIV infection.. Sexually Transmitted Infections. 66(2). 91–92. 12 indexed citations
15.
Rowe, Ian, Anne-Marie Deans, J Midgley, M. J. Anderson, & Andrew Keat. (1987). PARVOVIRUS INFECTION IN HOSPITAL PRACTICE. Lara D. Veeken. 26(1). 13–16. 8 indexed citations
16.
Shanson, D.C., David Johnstone, & J Midgley. (1985). Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: Value of an isolation unit. Journal of Hospital Infection. 6(3). 285–292. 44 indexed citations
17.
Shanson, D.C., J Midgley, Brian Gazzard, et al.. (1983). STREPTOBACILLUS MONILIFORMIS ISOLATED FROM BLOOD IN FOUR CASES OF HAVERHILL FEVER. The Lancet. 322(8341). 92–94. 37 indexed citations
18.
Dixey, Jonathan, et al.. (1982). Toxic-shock syndrome: four cases in a London hospital.. BMJ. 285(6338). 342–343. 6 indexed citations
19.
Phillips, Ian, J Midgley, & S. P. Lapage. (1970). Endocarditis due to a Pasteurella multocida-like organism.. PubMed. 47(8). 440–4. 12 indexed citations
20.
Midgley, J, et al.. (1970). Cardiobacterium Hominis Endocarditis. Journal of Medical Microbiology. 3(1). 91–98. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026